Retinitis pigmentosa as a clinical presentation of LCHAD deficiency: A clinical case and review of the literature.

• 发表时间: Sep 2021
• 来源期刊: Arch Soc Esp Oftalmol (Engl Ed)
• DOI: 10.1016/j.oftale.2020.07.013
• PMID: 34479707
• 文章类型: Case Reports
• 作者列表: García García LC,Zamorano Martín F,Rocha de Lossada C,García Lorente M,Luque Aranda G,Escudero Gómez J

关键词: 3-hidroxiacil CoA-deshidrogenasa de cadena larga; Beta-oxidation; Betaoxidación; Cribado neonatal; Long-chain 3-hydroxyacyl-CoA dehydrogenase; Newborn screening; Retinitis pigmentosa; Retinosis pigmentaria

Mesh: 3-Hydroxyacyl CoA Dehydrogenases; Cardiomyopathies; Child; Humans; Infant, Newborn; Lipid Metabolism, Inborn Errors; Mitochondrial Myopathies; Mitochondrial Trifunctional Protein / deficiency; Nervous System Diseases; Retinitis Pigmentosa / diagnosis; Rhabdomyolysis

Abstract

Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency is a rare metabolic disease caused by a specific mutation in the HADHA gene, which leads to an alteration in the metabolic pathway of fatty acids. Its most frequent form of presentation at the ophthalmological level is retinitis pigmentosa, and in some cases the ophthalmologist could be the first one to alert the other paediatric specialties to carry out a multidisciplinary approach to the case. The case is presented of a patient with long-chain 3-hydroxyacyl-CoA dehydrogenase deficit detected in neonatal screening, and which clinically debuted as pigmentary retinosis with no alteration in visual acuity as observed in the fundus images and optical coherence tomography of the retina provided. Finally, a review of the literature of this potentially lethal pathology is presented, and the main pathological and clinical features are highlighted.